Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Dolores Catania Teams Up with Advanced Herbals®, from the Makers of Dramamine®, to Launch The Dish on GLP-1s Content Series and Tackle One of the Most Common Complaints from GLP-1 Users: Nausea

Advanced Herbals NEW

News provided by

Dramamine

Jul 15, 2025, 09:33 ET

Share this article

Share toX

Share this article

Share toX

Advanced Herbals® and the reality TV star are sharing new, original content aimed to help the majority (64%) of GLP-1 users who wish they had more education about the medications' side effects 

TARRYTOWN, N.Y., July 15, 2025 /PRNewswire/ -- Side effects can crash the GLP-1 party – and most people aren't prepared for it. A survey commissioned by Advanced Herbals®, from the makers of Dramamine®, and Fleet® revealed that nausea and constipation are among the most common side effects reported by GLP-1 users, affecting 42% and 29% respectively – often without warning. Nearly two-thirds (64%) of GLP-1 users surveyed wished they had received more education about side effects prior to starting treatment, and 61% of users agreed the symptoms were more real than they had anticipated, indicating a potential gap in knowledge around GLP-1 side effects.

Continue Reading
Reality TV star Dolores Catania and Dr. Holly Lofton Team Up with Advanced Herbals®, from the Makers of Dramamine®, to Launch The Dish on GLP-1s Content Series and Tackle One of the Most Common Complaints from GLP-1 Users: Nausea
Reality TV star Dolores Catania and Dr. Holly Lofton Team Up with Advanced Herbals®, from the Makers of Dramamine®, to Launch The Dish on GLP-1s Content Series and Tackle One of the Most Common Complaints from GLP-1 Users: Nausea

To address the information gap and empower GLP-1 users with ongoing support during their health journeys, Advanced Herbals® is partnering with reality TV star Dolores Catania, to debut a new content series: "The Dish on GLP-1s." As a GLP-1 advocate who has spoken openly about her ups and downs with the medications, Catania is getting real about the one side effect that nearly derailed her progress and why she has used Advanced Herbals® Ginger Chews to help address her side effects – because nausea doesn't come with a heads up.

"When I first started my wellness journey with GLP-1 medications, I was prepared for weight loss and I was ready to feel different, but the nausea? No one prepared me for that," said Dolores Catania. "It really impacted my day-to-day life, but at the time no one was having these open, honest conversations about GLP-1 use – there was still a lot of stigma and speculation."

Real Talk + Real Expertise
The series, which debuted today on Dramamine.com/TheDishonGLP1, Instagram and YouTube, features candid conversations between Catania and Dr. Holly Lofton, a Board Certified Obesity Medicine Physician at NYU Langone. Dr. Lofton offers professional expertise, and Dolores Catania gets candid about her experiences as they unpack the real-life impact of GLP-1 side effects. Together, the two offer support and smart, stigma-free solutions, including how Advanced Herbals® Ginger Chews, with a clinically tested dose of ginger to help relieve nausea from morning sickness, motion sickness and upset stomach, may help individuals with nausea associated with their GLP-1 journey*.

"GLP-1 medications work by slowing the rate at which the stomach empties, helping users feel full longer and ultimately consume fewer calories, but this mechanism can also lead to symptoms like nausea, bloating and constipation," said Dr. Holly Lofton. "These early symptoms and side effects can ultimately derail proper use of the drug or even deter potential new patients. That's why non-prescription, convenient options, like Advanced Herbals® Ginger Chews for nausea and Fleet® Stimulant Oral Laxatives for constipation, can be helpful tools in managing these common side effects."

The series will air weekly across Dramamine's social platforms, offering relatable, expert-backed insights meant to inform, empower and resonate with the growing community of GLP-1 users looking for information on their wellness journeys. Follow @DramamineOfficial to learn more.

"As some of the most common symptoms of GLP-1 medications, nausea and constipation have proven to be jarring and disruptive for GLP-1 users," said Erica Nesbitt, Associate Marketing Director at Prestige Consumer Health. "All indicators point to increased accessibility and continued use of GLP-1 medications, so we saw an opportunity with Fleet® Oral Laxatives, Liquid Glycerin Suppositories and Advanced Herbals® Ginger Chews to help support those on a journey to improve their health."

Clinically Tested, Convenient Relief
Advanced Herbals® Ginger Chews, from the makers of Dramamine®, are crafted with ginger extract that helps to provide non-drowsy relief from multiple cases of nausea including upset stomach, morning sickness, motion sickness and occasional heartburn. With a great tasting lemon-honey-ginger flavor and a clinically tested dose of ginger extract, these soft chews are convenient and safe for frequent use. Fleet® Stimulant Oral Laxatives are a gentle, oral option for constipation relief that are easy to bring on the go and Fleet® Liquid Glycerin Suppositories provide fast relief for occasional constipation, working within minutes. Advanced Herbals® Ginger Chews and Fleet® Oral Laxatives and Liquid Glycerin Suppositories can be purchased at retailers including Amazon, Target, Walmart, Walgreens and CVS.

Survey Methodology: Advanced Herbals®, from the makers of Dramamine®, and Fleet conducted a consumer survey in collaboration with third-party research partner Opinium to obtain a nationally representative sample of ~ 1,000 U.S. adults who currently take GLP-1 medications. The survey was conducted in May 2025. 

About Dramamine®
With over 75 years of experience, Dramamine® is the leader in nausea relief and the #1 pharmacist recommended brand in motion sickness. Dramamine®'s range of solutions, in various forms, effectively prevent and treat nausea, dizziness, vomiting & queasiness. The brand is part of Prestige Consumer Healthcare, a leading consumer healthcare products company which markets over-the-counter products in the U.S., Canada and Australia.  For more information on Dramamine®, visit www.Dramamine.com. 

About Fleet® 
Fleet® is the #1 brand of enemas and suppositories, trusted for over 140 years to provide gentle, fast and effective relief from occasional constipation. Offering a range of over-the-counter solutions, Fleet® helps consumers manage digestive discomfort with confidence and convenience, no prescription required.  For more information, visit www.fleetlabs.com.

About Prestige Consumer Healthcare Inc. 
Prestige Consumer Healthcare is a leading consumer healthcare products company with sales throughout the U.S. and Canada, Australia, and in certain other international markets. The Company's diverse portfolio of brands include Monistat® and Summer's Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® and TheraTears® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux's Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com. 

*This statement has not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

SOURCE Dramamine

21%

more press release views with 
Request a Demo

Modal title

Also from this source

The Sandlot Star Patrick Renna Teams Up with Dramamine® to Revisit an Iconic Scene - This Time, Puke Free

The Sandlot Star Patrick Renna Teams Up with Dramamine® to Revisit an Iconic Scene - This Time, Puke Free

Advanced Herbals™, from the makers of Dramamine®, has partnered with actor Patrick Renna, best known for his role as Ham in The Sandlot, to give the...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Multimedia & Internet

Multimedia & Internet

Computer & Electronics

Computer & Electronics

Entertainment

Entertainment

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.